 CARLSBAD, Calif.--BUSINESS WIRE--- LCTX AMD--Lineage Cell Therapeutics, Inc. NYSE American and TASE: LCTX, a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, strongly endorses the recent passing of Proposition 14 in California. This bill will enhance patients access to groundbreaking stem cell therapy treatments by authorizing the California Institute for Regenerative Medicine CIRM the ability to fund up to 5.5 billion in grants to support therapeutic de 